New ML framework enhances drug discovery screening metrics

Researchers have developed a new machine learning framework to improve performance metric estimation in high-throughput screening (HTS) assays, which are crucial for early-stage drug discovery. The framework addresses the challenge of extreme data sparsity in HTS by deriving classification metrics like sensitivity and specificity from the strictly standardized mean difference (SSMD), a well-established effect-size parameter. This approach provides statistically principled and reproducible performance estimates, even with single-replicate measurements, as demonstrated in a hepatitis C virus screen. AI

IMPACT Enhances statistical rigor in drug discovery workflows, enabling more reliable hit selection from sparse data.

RANK_REASON The item is an academic paper detailing a new statistical framework for machine learning performance metrics in a specific scientific application. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv stat.ML →

• AUROC
• drug discovery
• Gaussian function
• Hepatitis C virus
• high-throughput screening
• machine learning
• noncentral t-distribution
• Xiaohua Douglas Zhang
• Youden's J statistic

• paper
• product

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →